Chemfab Alkalis Ltd vs Epigral Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 21, 2026

Key Highlights

The Latest Trading Price of Chemfab Alkalis Ltd is ₹ 356.85 as of 20 Mar 15:30 . The P/E Ratio of Chemfab Alkalis Ltd changed from 12.3 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 years The Market Cap of Chemfab Alkalis Ltd changed from ₹ 176.53 crore on March 2021 to ₹ 1013 crore on March 2025 . This represents a CAGR of 41.85% over 5 yearsThe Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2022 to ₹ 8191 crore on March 2025 . This represents a CAGR of 19.29% over 4 years The revenue of Chemfab Alkalis Ltd for the Dec '25 is ₹ 70.91 crore as compare to the Sep '25 revenue of ₹ 78.32 crore. This represent the decline of -9.46% The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The ebitda of Chemfab Alkalis Ltd for the Dec '25 is ₹ 4.71 crore as compare to the Sep '25 ebitda of ₹ 7.22 crore. This represent the decline of -34.76% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The net profit of Chemfab Alkalis Ltd changed from ₹ 0.9 crore to ₹ -4.45 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The Dividend Payout of Chemfab Alkalis Ltd changed from 6.12 % on March 2022 to 11.79 % on March 2025 . This represents a CAGR of 17.81% over 4 yearsThe Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 years .

About Chemfab Alkalis Ltd

Chemfab Alkalis Limited, formerly known as Teamec Chlorates Limited was incorporated on 06 May, 2009.
The name of the Company was changed from Teamec Chlorates Limited to Chemfab Alkalis Limited on July 21, 2017, vide Revised Certi?cate of Incorporation issued by the Registrar of Companies pursuant to the Scheme of Amalgamation dated 30 March 2017.
The Company is a manufacturer of caustic soda lye, ?akes, liquid chlorine, hydrogen gas, PVCO Pipes and other products.
The Company is engaged in manufacturing of basic inorganic chemicals and PVCO Pipes. In 1985, Company was first to install the Monopolar Electrolysers from M/s.
Chlorine Engineers Corporation, Japan (CEC).

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

FAQs for the comparison of Chemfab Alkalis Ltd and Epigral Ltd

Which company has a larger market capitalization, Chemfab Alkalis Ltd or Epigral Ltd?

Market cap of Chemfab Alkalis Ltd is 512 Cr while Market cap of Epigral Ltd is 3,676 Cr

What are the key factors driving the stock performance of Chemfab Alkalis Ltd and Epigral Ltd?

The stock performance of Chemfab Alkalis Ltd and Epigral Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chemfab Alkalis Ltd and Epigral Ltd?

As of March 21, 2026, the Chemfab Alkalis Ltd stock price is INR ₹356.85. On the other hand, Epigral Ltd stock price is INR ₹852.25.

How do dividend payouts of Chemfab Alkalis Ltd and Epigral Ltd compare?

To compare the dividend payouts of Chemfab Alkalis Ltd and Epigral Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.